Asynt's Felxible Gas Pressure Reactors
Asynt has announced a range of compact gas pressure reactors designed to be heated and stirred using standard hotplate stirrers with the unique DrySyn adapter that ensures excellent heat transfer.
The base vessels are available from 50 mL to 500 mL and are rated up to 200 Barr and 200 ºC enabling reactions including hydrogenation, carbonylation and carboxylation at elevated temperatures and pressures to be routinely performed.
With the added flexibility of standard and custom DrySyn inserts, Asynt gas pressure reactors provide chemists with a platform to undertake a single reaction from 100s of microlitres, by itself or in parallel, up to a single reaction to the volume of the vessel.
All vessels can be provided with a bursting disc, pressure gauge, pressure relief valve, PT100 temperature probe, thermowell for PT100, cooling coil, magnetic overhead stirrer with standard impeller (316 stainless steel), high pressure burette assembly and a range of glass or PTFE inserts and liners as well as PEEK internals if necessary.
For further information or to discuss your application please contact Asynt on +44 1638 781 709 or [email protected].
Related News
-
News Novartis signs US$3.2 bn subcutaneous delivery deal with Alteogen
Swiss pharma giant secures access to Korean biotech's ALT-B4 hyaluronidase platform in milestone-heavy agreement, marking Alteogen's fourth major licensing deal of 2026 as competition intensifies in the subcutaneous drug delivery space.
-
News Women in Pharma: The philosophy of pharmaceutical leadership
In this latest instalment of our Women in Pharma series, we sit down with Clarissa Sowemimo-Coker, Chief Strategy Officer at Ambrose Healthcare and CPHI Middle East Advisory Board Member.
-
News The PSCI Supplier Partnership - Collaboration for Responsible Supply Chains
About the Pharmaceutical Supply Chain Initiative The Pharmaceutical Supply Chain Initiative (PSCI) is the leading, member-led association for pharmaceutical companies working collaboratively to build responsible supply chains. Founded in 2006 and es... -
News AstraZeneca shares plunge 8.9% after reports of BMS talks
Britain's largest drugmaker lost more than GBP£17 billion in market value following reports of preliminary merger discussions with Bristol Myers Squibb that could create a pharmaceutical giant worth nearly US$400 billion, though investors rem... -
News GSK announces £400 million investment in new Cambridge R&D centre
Pharmaceutical giant to establish flagship research facility on Cambridge Biomedical Campus as part of strategic pipeline acceleration
-
News The CPHI Sustainability Summit - Where Conversation Becomes Collaboration
The Report Was Never the Destination - “The future of pharmaceutical sustainability won’t be shaped by individual organisations working in isolation. It will be shaped by partnerships, shared expertise and the willingness to work diffe... -
News Trump's generic drug tariffs set to reshape global pharmaceutical supply chains
The US president has announced plans to impose tariffs of up to 200% on imported generic medicines from August 2028, giving manufacturers a two-year window to establish domestic production facilities. The move threatens to upend a global supply chain t... -
News Building Safer, More Responsible Pharmaceutical Supply Chains: PSCI Global Audit Insights
The Pharmaceutical Supply Chain Initiative (PSCI) has released its seventh annual Audit Findings Analysis Report, offering unprecedented insights into supplier practices across the global pharmaceutical and healthcare industry.With a record-breaking 24...